NeuroOne Medical Technologies Corporation
NMTC
$3.39
-$0.07-2.02%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.05% | 11.20% | -7.88% | 33.90% | -227.18% |
| Total Depreciation and Amortization | -8.40% | 1.87% | -3.45% | 1.52% | 0.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | 100.00% | -140.68% |
| Total Other Non-Cash Items | 129.55% | -81.55% | 2,040.57% | 114.87% | 185.90% |
| Change in Net Operating Assets | 116.61% | -182.80% | -849.37% | -103.14% | 216.30% |
| Cash from Operations | 57.36% | -104.22% | -4.25% | -2,508.73% | -126.97% |
| Capital Expenditure | 5.64% | -284.91% | 75.63% | -1,259.38% | 86.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 5.64% | -284.91% | 75.63% | -1,259.38% | 86.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 284.40% | -- | -100.00% | 2,122.22% | -- |
| Repurchase of Common Stock | -1,588.89% | -28.57% | 20.00% | 96.73% | -847.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -132.86% | 107.19% | -1,472.12% | 87.61% |
| Cash from Financing | 312.45% | 120.60% | -99.19% | 3,255.02% | 148.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.82% | -104.78% | -121.87% | 3,514.52% | 157.08% |